Submitted by Sheldon Rampton on
Science reporting "is more and more the direct product of PR shops," according to Charles Petit, a veteran science reporter who runs MIT’s online Knight Science Journalism Tracker.
Submitted by Anne Landman on
Submitted by Bob Burton on
A cardinal rule amongst statisticians is to avoid comparing apples with oranges. But it seems that Danish statistician and climate change skeptic Bjorn Lomborg has no such reservations.
Submitted by Diane Farsetta on
The same month that Martin Philbert was named the chair of a U.S. Food and Drug Administration (FDA) panel considering the safety of bisphenol A, a defender of the chemical made a $5 million grant to Philbert's research center.
Submitted by Diane Farsetta on
Submitted by Diane Farsetta on
The U.S. Environmental Protection Agency (EPA) is poised to end "a six-year-old battle between career EPA scientists" who want to regulate a chemical linked to thyroid problems in pregnant women and children, and the White House and Pentagon, where officials oppose setting a drinking-water safety standard for the chemical, perchlorate. Guess who's likely to win?
Submitted by Sheldon Rampton on
Public interest groups, including the Center for Science in the Public Interest, are blasting the Food and Drug Administration for relying on industry-funded studies in evaluating the safety of bisphenol A, a chemical widely used in food packaging materials.
Submitted by Sheldon Rampton on
"The Ear and Hearing Journal has rebuked a Washington University researcher for failing to disclose that he was working as a paid expert for a siren manufacturer when he published a study saying firefighters weren't at risk for job-related hearing loss," reports David Armstrong. The study's author, William W. Clark of the Washington University School of Medicine in St.
Submitted by Bob Burton on
Sammy Wilson, the Northern Ireland Minister for Environment, is an avowed climate change skeptic who claims that "there is no conclusive evidence that greenhouse gases are a major cause of
Submitted by Diane Farsetta on
Pfizer's getting ready to resume advertising for its cholesterol drug Lipitor. In February, the drugmaker pulled its Lipitor ads, over charges they were misleading.
Center for Media and Democracy (CMD)
520 University Ave, Ste 305 • Madison, WI 53703 • (608) 229-6801
CMD is a 501(c)(3) tax-exempt non-profit.
© 1993-2021
A three-year, $7 million neuromarketing study done in Oxford, England has found that cigarette health warning labels actually make